Showing results (11-20 of 731) with videos related to
Sort By:
Pageof 74
Nature Reviews. Genetics|March 29, 2019
Resolving genetic heterogeneity in cancerSamra Turajlic, Andrea Sottoriva, Trevor Graham, et al.Therapeutic Advances in Medical Oncology|July 7, 2018
Immune-checkpoint inhibitors in melanoma and kidney cancer: from sequencing to rational selectionMichael Flynn, Lisa Pickering, James Larkin, et al.Therapeutic Advances in Medical Oncology|March 2, 2013
Targeted therapy and immunotherapy in advanced melanoma: an evolving paradigmMuhammad Khattak, Rosalie Fisher, Samra Turajlic, et al.Expert Opinion on Investigational Drugs|May 7, 2013
Phase I/II RAF kinase inhibitors in cancer therapySamra Turajlic, Zohra Ali, Nadia Yousaf, et al.Expert Review of Anticancer Therapy|April 21, 2011
Optimizing treatment of metastatic renal cell carcinoma by changing mechanism of actionJames Larkin, Charles Swanton, Lisa PickeringThe EPMA Journal|June 29, 2012
Delivering preventive, predictive and personalised cancer medicine for renal cell carcinoma: the challenge of tumour heterogeneityRosalie Fisher, James Larkin, Charles SwantonCancer Immunology, Immunotherapy : CII|November 14, 2016
Efficacy and toxicity of rechallenge with combination immune checkpoint blockade in metastatic melanoma: a case seriesLavinia Spain, Gerard Walls, Christina Messiou, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 16, 2020
Oligoprogression After Checkpoint Inhibition in Metastatic Melanoma Treated With Locoregional Therapy: A Single-center Retrospective AnalysisFrancesca Comito, Isla Leslie, Laura Boos, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2015
Translational implications of tumor heterogeneityMariam Jamal-Hanjani, Sergio A Quezada, James Larkin, et al.Cancer Cell|February 5, 2022
Metastasis and organotropism: A look through the lens of large-scale clinical sequencing dataAlexander Coulton, Samra TurajlicPageof 74